Harman Malhi

Harman Malhi is a scientist specializing in immunology and vaccine development, currently working at BioNTech SE as a Scientist in Systems Immunology since July 2024. Previous experience includes a role at Sail Biomedicines, where Harman focused on designing eRNA-based infectious disease vaccines and advancing preclinical vaccine development. At Fred Hutch, Harman completed a PhD in Molecular Medicine and Mechanisms of Disease, designing nanoparticle protein subunit vaccines and conducting research on HIV. Earlier positions at Fred Hutch involved mapping immune responses in vaccine trial participants and adhering to Good Clinical Lab Practice guidelines. Harman began an academic journey at the University of Washington, earning a BS in Molecular, Cellular, and Developmental Biology before obtaining the PhD.